Back to Search

CHUNG KUANG CHEN, MD

MD

Hospitalist Physician

NPI: 1427499961IndividualAccepts Medicare

Specialties, Licenses & Credentials

Hospitalist PhysicianPrimary

Hospitalist

Code: 208M00000X

58213(AZ)71521(WI)

CMS Specialties

PrimaryHOSPITALIST

Additional

INTERNAL MEDICINE

Education

OTHER

Class of 2007

Clinical Trials (1)

1
Linked Trials
0
Recruiting
1
With Results

Effects of Ezetimibe, Simvastatin, and Vytorin on Reducing L5 a Subfraction of LDL in Patients With Metabolic Syndrome.

NCT00988364COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR

Research & Publications (20)

Pro-apoptotic low-density lipoprotein subfractions in type II diabetes.
PMID 17030034·Atherosclerosis·2007
7-preclinical
Electronegative low-density lipoprotein.
PMID 15166790·Curr Opin Lipidol·2004
6-review
Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study.
PMID 14757686·Circulation·2004
8-other
Effects of ezetimibe added to on-going statin therapy on the lipid profile of hypercholesterolemic patients with diabetes mellitus or metabolic syndrome.
PMID 15383192·Curr Med Res Opin·2004
3-trial
Low-density lipoprotein in hypercholesterolemic human plasma induces vascular endothelial cell apoptosis by inhibiting fibroblast growth factor 2 transcription.
PMID 12695302·Circulation·2003
7-preclinical
Isolation, characterization, and functional assessment of oxidatively modified subfractions of circulating low-density lipoproteins.
PMID 12689919·Arterioscler Thromb Vasc Biol·2003
7-preclinical
Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial.
PMID 12719279·Circulation·2003
3-trial
LDL containing apolipoprotein CIII is an independent risk factor for coronary events in diabetic patients.
PMID 12637336·Arterioscler Thromb Vasc Biol·2003
8-other
Markers of triglyceride-rich lipoprotein remnant metabolism in visceral obesity.
PMID 11805008·Clin Chem·2002
8-other
Ezetimibe, a potent cholesterol absorption inhibitor, normalizes combined dyslipidemia in obese hyperinsulinemic hamsters.
PMID 11375333·Diabetes·2001
7-preclinical

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Request Appointment

Contact & Hours

Address
1296 Worcester Rd Apt 2310
Framingham, MA 01702

Locations (3)

Practice Location

1296 Worcester Rd Apt 2310, Framingham, MA
(310) 897-1983

Practice Location

2845 GREENBRIER RD, GREEN BAY, WI
(920) 288-8000

Practice Location

13400 E SHEA BLVD, SCOTTSDALE, AZ
(480) 301-8000

Quick Facts

NPI
1427499961
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
2
Locations
3
Years in Practice
19
Clinical Trials
1
Publications
20

Are you this provider?

Claim Your Profile